FI954805A0 - Methods for using insulin-like growth factor binding proteins - Google Patents

Methods for using insulin-like growth factor binding proteins

Info

Publication number
FI954805A0
FI954805A0 FI954805A FI954805A FI954805A0 FI 954805 A0 FI954805 A0 FI 954805A0 FI 954805 A FI954805 A FI 954805A FI 954805 A FI954805 A FI 954805A FI 954805 A0 FI954805 A0 FI 954805A0
Authority
FI
Finland
Prior art keywords
insulin
methods
growth factor
binding proteins
factor binding
Prior art date
Application number
FI954805A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI954805A (en
Inventor
George N Cox
Deborah A Russell
Original Assignee
Amgen Boulder Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Boulder Inc filed Critical Amgen Boulder Inc
Publication of FI954805A0 publication Critical patent/FI954805A0/en
Publication of FI954805A publication Critical patent/FI954805A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI954805A 1993-04-07 1995-10-09 Methods for using insulin-like growth factor binding proteins FI954805A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4526593A 1993-04-07 1993-04-07
PCT/US1994/003755 WO1994022466A1 (en) 1993-04-07 1994-04-06 Methods of using insulin-like growth factor binding proteins

Publications (2)

Publication Number Publication Date
FI954805A0 true FI954805A0 (en) 1995-10-09
FI954805A FI954805A (en) 1995-11-15

Family

ID=21936902

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954805A FI954805A (en) 1993-04-07 1995-10-09 Methods for using insulin-like growth factor binding proteins

Country Status (7)

Country Link
EP (1) EP0708655A1 (en)
JP (1) JPH08508296A (en)
CN (1) CN1134111A (en)
AU (1) AU6626794A (en)
CA (1) CA2160154A1 (en)
FI (1) FI954805A (en)
WO (1) WO1994022466A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995032003A1 (en) * 1994-05-24 1995-11-30 Amgen Boulder Inc. Modified insulin-like growth factors
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
WO1999003887A1 (en) 1997-07-14 1999-01-28 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
AU6515499A (en) * 1998-10-16 2000-05-08 Musc Foundation For Research Development Fragments of insulin-like growth factor binding protein and insulin-like growth factor, and uses thereof
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
EP2305804B1 (en) 1999-01-14 2015-05-06 Bolder Biotechnology, Inc. MonoPEGylated human growth hormone
AU3579200A (en) * 1999-02-26 2000-09-14 Saltech I Goteborg Ab Method and composition for the regulation of hepatic and extrahepatic productionof insulin-like growth factor-1
AUPR030900A0 (en) * 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
WO2003029420A2 (en) 2001-10-02 2003-04-10 Genentech, Inc. Apo-2 ligand variants and uses thereof
AU2003247609A1 (en) 2002-06-24 2004-01-06 Genentech, Inc. Apo-2 ligand/trail variants and uses thereof
WO2005033132A2 (en) 2003-10-03 2005-04-14 Genentech, Inc. Igf binding proteins
US8329866B2 (en) 2005-10-03 2012-12-11 Bolder Biotechnology, Inc. Long acting VEGF inhibitors and methods of use
CA2659585A1 (en) * 2006-08-16 2008-02-21 National Research Council Of Canada Inhibition of angiogenesis, tumorigenesis and cathepsin activity using insulin-like growth factor binding protein
MX2016001854A (en) 2013-08-12 2016-09-06 Genentech Inc Compositions and method for treating complement-associated conditions.
TW201623337A (en) 2014-05-01 2016-07-01 建南德克公司 Anti-Factor D antibody variants and uses thereof
JP2018536650A (en) 2015-10-30 2018-12-13 ジェネンテック， インコーポレイテッド Anti-factor D antibody variant conjugates and uses thereof
US10407510B2 (en) 2015-10-30 2019-09-10 Genentech, Inc. Anti-factor D antibodies and conjugates
US11179451B2 (en) * 2016-11-01 2021-11-23 Virginia Commonwealth University Methods of treating an IGFBP-3R expressing cancer using anti-IGFBP-3R antibodies
BR112022018847A2 (en) 2020-03-24 2022-11-22 Genentech Inc ANTIBODIES, NUCLEIC ACID, HOST CELL, CONJUGATES, PHARMACEUTICAL COMPOSITION, LONG-ACTION DELIVERY DEVICE FOR OCULAR DELIVERY, METHOD FOR TREAT A DISORDER AND USE OF THE ANTIBODY
CN116144667B (en) * 2022-12-29 2024-03-12 海南大学 Egg-shaped pompano insulin-like growth factor binding protein 1 gene, protein and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK131988A (en) * 1988-03-11 1989-09-12 Erasmus University IGF BINDING PROTEIN, DNA STRUCTURE CODING FOR IGF BINDING PROTEIN AND VECTOR CONTAINING THIS DNA STRUCTURE
JPH03504597A (en) * 1988-04-12 1991-10-09 シナージェン，インコーポレーテッド Methods for enhancing and inhibiting insulin-like growth factor activity
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds
CA2288429C (en) * 1991-03-15 2006-04-25 Synergen, Inc. Pegylation of polypeptides

Also Published As

Publication number Publication date
CN1134111A (en) 1996-10-23
JPH08508296A (en) 1996-09-03
EP0708655A1 (en) 1996-05-01
AU6626794A (en) 1994-10-24
CA2160154A1 (en) 1994-10-13
FI954805A (en) 1995-11-15
WO1994022466A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
FI954805A (en) Methods for using insulin-like growth factor binding proteins
GB9225453D0 (en) Binding proteins
FI973543A (en) Method for preparing heteromultimeric polypeptides
DE69410636D1 (en) BINDING
IL107742A0 (en) Chemically-modified binding proteins
FI961071A0 (en) Method for preparing zeolite
AU5283793A (en) Recombinant specific binding protein
AU2866695A (en) E6 binding proteins
DE69413830D1 (en) METHOD FOR SULFONING OLEFINS WITH INTERNAL DOUBLE BINDING
DK132892D0 (en) PROTEINS
ZA975202B (en) Plants proteins
EP0796321A4 (en) E2 binding proteins
DE69423487D1 (en) FACILITIES FOR AQUACULTURE
GB9314802D0 (en) Modified proteins
EP0546081A4 (en) New insulin-like growth factor binding protein (igfbp-4)
AU3640397A (en) Ob protein binding protein
HU9400526D0 (en) Anti-microbial proteins
IL115317A0 (en) Proteins
GB9413316D0 (en) Novel proteins
DE69223434D1 (en) Calmodulin binding protein
IT1248875B (en) METHOD FOR BINDING BOOKS
SE9202720D0 (en) FIBRINOGEN BINDING PROTEIN
GB9313070D0 (en) Binding protein
AU4795493A (en) Salicylic acid binding protein
EP0751784A4 (en) Thyroxin-binding proteins

Legal Events

Date Code Title Description
FD Application lapsed